Literature DB >> 24289885

Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia.

Ashley M Fenn1, John C Gensel2, Yan Huang1, Phillip G Popovich3, Jonathan Lifshitz4, Jonathan P Godbout5.   

Abstract

BACKGROUND: Traumatic brain injury (TBI) is associated with a higher incidence of depression. The majority of individuals who suffer a TBI are juveniles and young adults, and thus, the risk of a lifetime of depressive complications is a significant concern. The etiology of increased TBI-associated depression is unclear but may be inflammatory-related with increased brain sensitivity to secondary inflammatory challenges (e.g., stressors, infection, and injury).
METHODS: Adult male BALB/c mice received a sham (n = 52) or midline fluid percussion injury (TBI; n = 57). Neuroinflammation, motor coordination (rotarod), and depressive behaviors (social withdrawal, immobility in the tail suspension test, and anhedonia) were assessed 4 hours, 24 hours, 72 hours, 7 days, or 30 days later. Moreover, 30 days after surgery, sham and TBI mice received a peripheral injection of saline or lipopolysaccharide (LPS) and microglia activation and behavior were determined.
RESULTS: Diffuse TBI caused inflammation, peripheral cell recruitment, and microglia activation immediately after injury coinciding with motor coordination deficits. These transient events resolved within 7 days. Nonetheless, 30 days post-TBI a population of deramified and major histocompatibility complex II(+) (primed) microglia were detected. After a peripheral LPS challenge, the inflammatory cytokine response in primed microglia of TBI mice was exaggerated compared with microglia of controls. Furthermore, this LPS-induced microglia reactivity 30 days after TBI was associated with the onset of depressive-like behavior.
CONCLUSIONS: These results implicate a primed and immune-reactive microglial population as a possible triggering mechanism for the development of depressive complications after TBI.
© 2013 Society of Biological Psychiatry Published by Society of Biological Psychiatry All rights reserved.

Entities:  

Keywords:  Cytokines; depression; fluid percussion injury; lipopolysaccharide; major histocompatibility complex II; microglia

Mesh:

Substances:

Year:  2013        PMID: 24289885      PMCID: PMC4000292          DOI: 10.1016/j.biopsych.2013.10.014

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  72 in total

1.  Cytokine production and treatment response in major depressive disorder.

Authors:  S Lanquillon; J C Krieg; U Bening-Abu-Shach; H Vedder
Journal:  Neuropsychopharmacology       Date:  2000-04       Impact factor: 7.853

2.  Neuroinflammatory responses after experimental diffuse traumatic brain injury.

Authors:  Brian Joseph Kelley; Jonathan Lifshitz; John Theodore Povlishock
Journal:  J Neuropathol Exp Neurol       Date:  2007-11       Impact factor: 3.685

3.  Microglia and memory: modulation by early-life infection.

Authors:  Lauren L Williamson; Paige W Sholar; Rishi S Mistry; Susan H Smith; Staci D Bilbo
Journal:  J Neurosci       Date:  2011-10-26       Impact factor: 6.167

4.  Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice.

Authors:  Ashley M Fenn; Christopher J Henry; Yan Huang; Allison Dugan; Jonathan P Godbout
Journal:  Brain Behav Immun       Date:  2011-10-17       Impact factor: 7.217

5.  Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat.

Authors:  F O Maher; Yvonne Nolan; Marina A Lynch
Journal:  Neurobiol Aging       Date:  2005-05       Impact factor: 4.673

6.  Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease.

Authors:  Colm Cunningham; Suzanne Campion; Katie Lunnon; Carol L Murray; Jack F C Woods; Robert M J Deacon; J Nicholas P Rawlins; V Hugh Perry
Journal:  Biol Psychiatry       Date:  2008-09-18       Impact factor: 13.382

7.  An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology.

Authors:  Dustin J Donnelly; John C Gensel; Daniel P Ankeny; Nico van Rooijen; Phillip G Popovich
Journal:  J Neurosci Methods       Date:  2009-04-23       Impact factor: 2.390

8.  Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice.

Authors:  Angela W Corona; Diana M Norden; John P Skendelas; Yan Huang; Jason C O'Connor; Marcus Lawson; Robert Dantzer; Keith W Kelley; Jonathan P Godbout
Journal:  Brain Behav Immun       Date:  2012-08-19       Impact factor: 7.217

9.  Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries.

Authors:  T Kossmann; V H Hans; H G Imhof; R Stocker; P Grob; O Trentz; C Morganti-Kossmann
Journal:  Shock       Date:  1995-11       Impact factor: 3.454

10.  Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium.

Authors:  Carol Murray; David J Sanderson; Chris Barkus; Robert M J Deacon; J Nicholas P Rawlins; David M Bannerman; Colm Cunningham
Journal:  Neurobiol Aging       Date:  2010-05-14       Impact factor: 4.673

View more
  94 in total

1.  In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.

Authors:  Seoyeon Bok; Taejun Wang; Chan-Ju Lee; Seong-Uk Jeon; Young-Eun Kim; Jeongwoo Kim; Beom-Ju Hong; Calvin Jinse Yoon; Sungjee Kim; Seung-Hoon Lee; Hak Jae Kim; Il Han Kim; Ki Hean Kim; G-One Ahn
Journal:  Biomed Opt Express       Date:  2015-08-07       Impact factor: 3.732

2.  Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge.

Authors:  Diana M Norden; Paige J Trojanowski; Emmanuel Villanueva; Elisa Navarro; Jonathan P Godbout
Journal:  Glia       Date:  2015-10-15       Impact factor: 7.452

Review 3.  Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

4.  Traumatic Brain Injury Causes Chronic Cortical Inflammation and Neuronal Dysfunction Mediated by Microglia.

Authors:  Kristina G Witcher; Chelsea E Bray; Titikorn Chunchai; Fangli Zhao; Shane M O'Neil; Alan J Gordillo; Warren A Campbell; Daniel B McKim; Xiaoyu Liu; Julia E Dziabis; Ning Quan; Daniel S Eiferman; Andy J Fischer; Olga N Kokiko-Cochran; Candice Askwith; Jonathan P Godbout
Journal:  J Neurosci       Date:  2021-01-15       Impact factor: 6.167

Review 5.  Microglial priming in Alzheimer's disease.

Authors:  Jun-Wei Li; Yu Zong; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

Review 6.  Making sense of gut feelings in the traumatic brain injury pathogenesis.

Authors:  Luiz Fernando Freire Royes; Fernando Gomez-Pinilla
Journal:  Neurosci Biobehav Rev       Date:  2019-05-16       Impact factor: 8.989

7.  Elevated Serum Levels of Neopterin at Admission Predicts Depression After Acute Ischemic Stroke: a 6-Month Follow-Up Study.

Authors:  Chao-Zhi Tang; Yu-Ling Zhang; Wen-Sheng Wang; Wei-Guo Li; Ji-Peng Shi
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

Review 8.  In-depth conversation: spectrum and kinetics of neuroimmune afferent pathways.

Authors:  Ning Quan
Journal:  Brain Behav Immun       Date:  2014-02-22       Impact factor: 7.217

Review 9.  Found in translation: Understanding the biology and behavior of experimental traumatic brain injury.

Authors:  Corina O Bondi; Bridgette D Semple; Linda J Noble-Haeusslein; Nicole D Osier; Shaun W Carlson; C Edward Dixon; Christopher C Giza; Anthony E Kline
Journal:  Neurosci Biobehav Rev       Date:  2014-12-10       Impact factor: 8.989

Review 10.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.